Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation (Q34548497)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Lucille N Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Richard G Stock

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nelson N Stone

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

444-452

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: Implications for patient selection in the radiotherapeutic management of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of androgen suppression and radiotherapy for patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of intermediate-risk prostate cancer patients treated with radiotherapy suitable for neoadjuvant hormone studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose combination radiotherapy for the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902598-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)02598-6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34548497&oldid=1983302211"